DR. RUSSELL ROSENBLATT

NEW YORK, NY

Research Active
Internal Medicine - Hepatology NPI registered 15+ years 50 publications 2022 – 2026 NPI: 1114217635

Practice Location

1305 YORK AVE FL 4
NEW YORK, NY 10021-5663

Phone: (646) 962-5483

What does RUSSELL ROSENBLATT research?

Russell Rosenblatt studies liver diseases, particularly cirrhosis and hepatitis B, and how these conditions interact with patients' overall health outcomes. He investigates issues such as how socioeconomic factors influence patient perceptions of healthcare quality and the treatment and survival disparities among different racial and ethnic groups with liver cancer. Additionally, he explores connections between liver health and risks for other serious conditions like heart disease and stroke. His research aims to identify systemic gaps in care and promote strategies for improving treatment access and outcomes for individuals suffering from liver-related ailments.

Key findings

  • In a study on cirrhotic cardiomyopathy, 23% of 208 patients with worsening liver disease exhibited this heart dysfunction, with those having higher MELD-Na scores significantly more likely to be affected.
  • Research revealed that patients with alcohol-related liver disease faced nearly three times the 30-day mortality compared to those without liver disease, highlighting the critical need for early identification and management.
  • A study found that patients with a high liver fibrosis score had double the risk of experiencing a hemorrhagic stroke, indicating that undiagnosed liver scarring can contribute to severe stroke risk.
  • Disparities in treatment outcomes were observed in Asian American patients with liver cancer; when analyzed as a single group, terminal mortality rates masked significantly higher risks in Southeast Asian and Native Hawaiian/Pacific Islander subgroups.
  • The Affordable Care Act's Medicaid expansion led to increased access to the liver transplant waitlist without worsening survival rates, allowing more patients to seek necessary care.

Frequently asked questions

Does Dr. Rosenblatt study liver disease?
Yes, Dr. Rosenblatt focuses on various aspects of liver disease, including cirrhosis and hepatitis B.
What treatments has Dr. Rosenblatt researched?
He researches treatments related to liver diseases, especially focusing on how disparities affect survival and access to care.
Is Dr. Rosenblatt's work relevant to patients with chronic liver disease?
Absolutely, his studies directly address issues that affect patients with chronic liver conditions, aiming to improve care and outcomes.
What are the key health disparities identified in Dr. Rosenblatt's studies?
His research highlights significant disparities based on socioeconomic status and ethnicity, particularly in the treatment and outcomes for liver disease patients.
How does Dr. Rosenblatt's work impact the management of liver disease?
By identifying critical factors influencing health outcomes, his research helps shape better clinical practices and policy changes to enhance patient care.

Publications in plain English

Geographic Distribution of Physician Workforce with H-1B in the United States.

2026

Journal of general internal medicine

Ying X, Reznik E, Chen V, Lee M, Rosenblatt R +1 more

PubMed

Disparities and Trends in Industry Sponsored Research Payments to Physicians 2014-2021.

2026

Journal of general internal medicine

Ying X, Eghbali S, Pinto L, Purkayastha S, Jesudian AB +2 more

PubMed

Socioeconomic Factors Impact the Perception of Healthcare Experiences in Patients with Cirrhosis.

2026

Digestive diseases and sciences

Ng N, Purkayastha S, Ying X, Jesudian A, Rosenblatt R

Plain English
This study used a large national database to look at whether patients with cirrhosis from different income levels reported different experiences with their doctors. Patients earning under $35,000 a year were significantly more likely to feel treated with less courtesy and to receive poorer service, while women were more likely to feel they weren't listened to. These findings identify clear gaps in the patient-provider relationship that could worsen health outcomes for low-income and female patients with liver disease.

PubMed

Severity of liver disease is associated with cirrhotic cardiomyopathy: A multicenter study.

2026

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Ying X, Oje AO, De Witte AJ, Slaughter JC, Spann AL +11 more

Plain English
Researchers examined whether worsening liver disease is linked to a specific type of heart dysfunction called cirrhotic cardiomyopathy in patients awaiting liver transplant. Among 208 patients, 23% had this condition, and those with more severe liver disease—measured by higher MELD-Na scores and worse ascites—were significantly more likely to have it. This matters because recognizing this cardiac problem early could improve how transplant candidates are selected and monitored.

PubMed

Association between elevated fibrosis-4 index of liver fibrosis and risk of hemorrhagic stroke.

2025

European stroke journal

Parikh NS, Zhang C, Bruce SS, Murthy SB, Rosenblatt R +6 more

Plain English
Using data from nearly half a million UK adults, researchers tested whether a blood-test-based score for liver scarring was linked to a higher risk of bleeding strokes. People with a high liver fibrosis score had twice the risk of hemorrhagic stroke compared to those without, even after accounting for factors like high blood pressure and alcohol use. This finding suggests that liver scarring—often undetected—may be an important and overlooked contributor to stroke risk.

PubMed

Introducing the History, Culture, and Liver Disease series.

2025

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Rosenblatt R

PubMed

The trials, tribulations, and triumph of Ulysses S. Grant with alcohol.

2025

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Rosenblatt R

PubMed

Treatment and Survival Disparities in Asian Americans With Hepatocellular Carcinoma: The Need to Disaggregate a Diverse Cohort.

2025

Journal of clinical gastroenterology

Hu R, Ying X, Ng N, Lieu R, Jesudian A +3 more

Plain English
This study examined treatment and survival differences among Asian American patients with early-stage liver cancer using a national cancer database. When the Asian American group was looked at as a whole, outcomes appeared better than for white patients, but breaking the group apart revealed major disparities: Southeast Asian and Native Hawaiian/Pacific Islander patients had significantly higher mortality rates. Treating Asian Americans as a single group masks serious health inequities that require targeted attention from clinicians and policymakers.

PubMed

Medicaid and Medicare Utilization of Direct-Acting Antiviral Medications for Patients With Hepatitis C.

2025

Gastro hep advances

Ying X, Zhao A, Ng N, Rosenblatt R, Lucero C +1 more

PubMed

A closer look at gender disparities in patients with pulmonary embolism.

2025

Proceedings (Baylor University. Medical Center)

Chen C, Rosenblatt R

PubMed

Detecting and managing arrhythmic mitral valve prolapse.

2025

Proceedings (Baylor University. Medical Center)

Rao PK, Tandon A, Wang H, Blough B, Rosenblatt R +2 more

Plain English
This paper describes a patient who suffered cardiac arrest caused by an unusual condition called arrhythmic mitral valve prolapse, a rare but potentially deadly heart valve problem. The case prompted a review of what warning signs clinicians should look for on standard tests like an EKG and echocardiogram to identify patients at risk before a life-threatening event occurs. The authors argue that targeted awareness of specific features can help justify more advanced imaging in the right patients.

PubMed

Prescriber Specialty Involvement in Medicare Patients With Chronic Hepatitis B.

2025

Journal of viral hepatitis

Ying X, Ng N, Reidy D, Azari J, Rosenblatt R +3 more

Plain English
Researchers tracked who prescribed antiviral medications for chronic hepatitis B patients on Medicare between 2013 and 2021. Gastroenterologists and advanced practice providers took on an increasingly larger share of prescribing, while infectious disease specialists prescribed less over time. The growth of advanced practice providers in managing hepatitis B is a promising development given doctor shortages, though it signals the need for better care coordination models.

PubMed

Have we made progress in preventing deaths attributed to asthma?

2025

Proceedings (Baylor University. Medical Center)

Yoshino K, Abdelmonem A, Rosenblatt R

PubMed

Prognostic Factors in Alcohol-associated Liver Disease Patients Presenting With First Evidence of Ascites.

2024

Journal of clinical gastroenterology

Fahoum K, Shen NT, Basu E, Lee J, Kaplan A +7 more

Plain English
Researchers followed patients with alcohol-related liver disease from the moment they first developed ascites—a sign of serious liver decline—and identified factors linked to transplantation or death. Younger age and higher sodium levels were associated with getting a transplant, while higher BMI, more health conditions, and a recent period of abstinence after heavy drinking were linked to death. These early predictors could help clinicians better counsel and risk-stratify patients at this critical disease turning point.

PubMed

Affordable Care Act Medicaid expansion associated with increased liver transplant waitlist access without worsening mortality.

2024

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Wahid N, Lee J, Rosenblatt R, Kaplan A, Tipirneni R +3 more

Plain English
This study evaluated whether the Affordable Care Act's Medicaid expansion changed who gets on the liver transplant waitlist and how they fare. Medicaid use on the waitlist increased substantially in states that expanded coverage, while waitlist mortality was unchanged and transplant rates for Medicaid patients improved slightly. The results indicate that broadening Medicaid access increases the number of people who can pursue transplantation without harming overall waitlist outcomes.

PubMed

Liver Severity Score-Based Modeling to Predict Six-Week Mortality Risk Among Hospitalized Cirrhosis Patients With Upper Gastrointestinal Bleeding.

2024

Journal of clinical and experimental hepatology

Wong R, Buckholz A, Hajifathalian K, Ng C, Sholle E +3 more

Plain English
Researchers tested how well liver severity scores predict six-week mortality in cirrhosis patients hospitalized with upper gastrointestinal bleeding, regardless of whether the bleeding was caused by portal hypertension. Both the Child-Turcotte-Pugh and MELD scores showed strong predictive accuracy, but only the Child-Turcotte-Pugh score performed well across all types of bleeding. This means clinicians can use this score before performing an endoscopy to quickly classify patients as low, moderate, or high risk.

PubMed

Patients with early-stage alcohol-associated liver disease are at increased risk of hospital readmission and death.

2024

European journal of gastroenterology & hepatology

Aryan M, Qian S, Chen Z, Louissaint J, Qian X +6 more

Plain English
This study followed over 7,500 hospitalized patients with alcohol use disorder to examine whether early, mild alcohol-related liver damage—before cirrhosis develops—affects outcomes. Patients with early liver injury had nearly three times the 30-day mortality compared to those with no liver disease, and were also more likely to be readmitted within 30 days. The findings show that early alcohol-related liver disease is far from benign and needs to be actively identified and managed.

PubMed

Interaction of AI-Enabled Quantitative Coronary Plaque Volumes on Coronary CT Angiography, FFR, and Clinical Outcomes: A Retrospective Analysis of the ADVANCE Registry.

2024

Circulation. Cardiovascular imaging

Dundas J, Leipsic J, Fairbairn T, Ng N, Sussman V +22 more

Plain English
This study used AI tools to measure the volume and type of coronary artery plaque in over 4,000 patients who had heart CT scans, then tracked which patients had heart attacks or needed procedures within a year. Higher total plaque volume and percentage of plaque relative to artery size predicted worse outcomes, even after accounting for blockage severity and blood flow measurements. Quantifying plaque volume adds meaningful risk information beyond what standard CT-based measures alone provide.

PubMed

Superior vena cava syndrome in lung cancer: an interesting observation.

2024

Proceedings (Baylor University. Medical Center)

Rosenblatt R

PubMed

Pragmatic strategies to address health disparities along the continuum of care in chronic liver disease.

2024

Hepatology communications

Brahmania M, Rogal S, Serper M, Patel A, Goldberg D +25 more

Plain English
This review outlines the racial, ethnic, and socioeconomic gaps that affect patients with chronic liver disease at every stage of care, from initial screening through liver transplantation. It uses a health equity framework to identify specific barriers and offers practical, evidence-based strategies for providers and health systems to deliver more equitable care. The goal is to give clinicians concrete tools rather than simply documenting that disparities exist.

PubMed

Racial Disparities in Cost and Non-Cost Barriers to Care: An Analysis of the All of Us Survey.

2024

Journal of general internal medicine

Ying X, Zhang R, Purkayastha S, Ng N, Rosenblatt R +2 more

PubMed

Differential Access to Breast Magnetic Resonance Imaging Compared with Mammography and Ultrasound.

2024

American journal of preventive medicine

Christensen EW, Rosenblatt RB, Patel AG, Rula EY, Carlos RC +2 more

Plain English
Researchers mapped the geographic distance between zip codes and the nearest breast imaging facilities across the United States, comparing MRI, mammography, and ultrasound. On average, breast MRI facilities were nearly three times farther away than mammography sites, with the gap widest for people in rural and lower-income areas. The findings highlight a structural access problem for high-risk women who need MRI screening and suggest that contrast-enhanced mammography at existing sites could help close the gap.

PubMed

Predictors of Acute Kidney Injury Resolution and Associated Clinical Outcomes Among Hospitalized Patients with Cirrhosis.

2024

Journal of clinical medicine

Abboud Y, Rajan A, Rosenblatt RE, Tow C, Jesudian A +2 more

Plain English
This study looked at what predicts whether kidney injury will resolve in hospitalized cirrhosis patients, and what happens to those whose kidney function doesn't improve by discharge. Higher albumin levels on admission and having a non-fatty-liver cause of cirrhosis were linked to better chances of kidney recovery, while more severe kidney injury at admission predicted worse odds. Patients whose kidney injury didn't resolve had much higher short- and long-term mortality, underscoring the urgency of aggressive treatment.

PubMed

No Improvement in Intention-to-treat Survival and Increasing Liver Nonutilization Rate During the MELD Era.

2024

Transplantation

Matsumoto R, Verna EC, Rosenblatt R, Emond JC, Brown RS +4 more

Plain English
Researchers analyzed two decades of national liver transplant data and found that while survival after transplant has steadily improved, survival from the time of waitlist listing has not. Over the same period, the rate of donated livers going unused rose significantly, as did the rate of patients dropping off the waitlist before receiving a transplant. This suggests that gains in post-transplant care are being offset by more patients dying while waiting, partly because usable organs are being declined.

PubMed

Understanding Prognosis: Discrepancy in Prognosis Estimates Between Patients With Cirrhosis and their Hepatologists.

2023

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Kaplan A, Comisar L, Ufere NN, Jannat-Khah D, Rosenblatt R +3 more

Plain English
Researchers asked 70 cirrhosis patients and their liver specialists to independently estimate how long the patient would live with and without a transplant, then compared those estimates. Patients were significantly more optimistic than their doctors, and their survival estimates bore little relationship to their actual disease severity scores. Better alignment between patients and providers on prognosis is essential for patients to make informed decisions about pursuing transplantation or other care options.

PubMed

Remote monitoring of cognition in cirrhosis and encephalopathy: future opportunity and challenge.

2023

Metabolic brain disease

Buckholz AP, Rosenblatt R

Plain English
This review examines the potential of mobile technology and smartphone-based tools to assess cognitive function in patients with hepatic encephalopathy, a complication of liver disease that causes brain dysfunction. Current diagnostic tests are underused and imprecise, but digital tools could allow for real-time, continuous cognitive monitoring outside of clinic visits. The authors discuss both the promise and the significant practical, ethical, and reliability challenges that must be solved before these tools can be widely adopted.

PubMed

Confronting Disparities in Telehepatology Research.

2023

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Louissaint J, Wilder JM, Tapper EB, Rodriguez JA, Rosenblatt R +1 more

PubMed

Renal transplantation using kidneys from hepatitis C-infected donors: A review of 30-years' experience.

2023

Nefrologia

Sawinski D, Rosenblatt RE, Morales JM

Plain English
This review examines three decades of experience using kidneys from hepatitis C-positive donors in kidney transplantation, including the now-common practice of transplanting these organs into hepatitis-C-negative recipients. It outlines how the development of highly effective direct-acting antiviral drugs transformed this once-controversial approach into a viable strategy for expanding the organ supply. The review provides a historical and practical framework for centers considering or already using this approach.

PubMed

Liver transplant at all costs.

2023

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Kaplan A, Aby ES, Rosenblatt R

PubMed

Evaluating sleep in covert encephalopathy with wearable technology: results from the WATCHES study.

2023

Hepatology communications

Buckholz A, Clarke L, Paik P, Jesudian A, Schwartz R +3 more

Plain English
This study used commercial fitness trackers to monitor sleep in 25 cirrhosis patients over six months, testing whether wearable devices could detect early-stage brain dysfunction known as covert hepatic encephalopathy. Patients with this condition consistently had about one hour less restorative sleep per night, and a model combining sleep data with lab values showed good accuracy in identifying who had it. The findings open the door to passive, continuous monitoring of a complication that is currently underdiagnosed and hard to test for in practice.

PubMed

Integration of Cirrhosis Best Practices Into Electronic Medical Record Documentation Associated With Reduction in 30-Day Mortality Following Hospitalization.

2023

Journal of clinical gastroenterology

Sherman Z, Wahid N, Wagner M, Soltani A, Rosenblatt R +5 more

Plain English
Researchers tested whether prompting hospital teams to document cirrhosis best practices—using a structured electronic medical record template—would improve patient outcomes. Patients cared for by teams using the template had significantly lower 30-day mortality (8.4% vs. 28%) and higher rates of a key diagnostic procedure for ascites. The results suggest that embedding clinical guidelines directly into the documentation workflow can translate into real survival benefits for hospitalized cirrhosis patients.

PubMed

CAQ Corner: Infections in liver transplant recipients.

2023

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Rosenblatt R, Kodiyanplakkal RP

PubMed

CAQ Corner: Evaluation and management of living liver donors.

2023

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Pillai A, Goldaracena N, Rosenblatt R, Verna EC

PubMed

Management of Stroke in Patients With Chronic Liver Disease: A Practical Review.

2023

Stroke

Parikh NS, Basu E, Hwang MJ, Rosenblatt R, VanWagner LB +3 more

Plain English
This review addresses the management of stroke in patients who also have chronic liver disease, filling a significant gap in existing stroke guidelines. Chronic liver disease disrupts clotting, platelet counts, drug metabolism, and other factors that directly affect stroke risk and treatment decisions. The review provides vascular neurologists with practical guidance on both the unique stroke risks these patients face and the challenges of treating them with standard stroke medications.

PubMed

Impact of Race and Neighborhood Socioeconomic Characteristics on Liver Cancer Diagnosis in Patients with Viral Hepatitis and Cirrhosis.

2023

Journal of clinical and experimental hepatology

Ying X, Pan Y, Rosenblatt R, Ng C, Sholle E +3 more

Plain English
This study investigated whether race and neighborhood characteristics—such as poverty levels, education, and language barriers—affect the likelihood of being diagnosed with advanced liver cancer among patients with viral hepatitis and cirrhosis in New York City. Asian race and low household income were independently associated with a higher chance of being diagnosed at an advanced, harder-to-treat stage. The findings point to failures in cancer screening programs for vulnerable populations and the need for targeted outreach.

PubMed

Invasive fungal infections in liver diseases.

2023

Hepatology communications

Barros N, Rosenblatt RE, Phipps MM, Fomin V, Mansour MK

Plain English
This review covers invasive fungal infections in patients with serious liver disease, including cirrhosis, alcoholic hepatitis, and liver transplant recipients. It explains why these patients are particularly vulnerable—due to immune dysfunction, malnutrition, and disrupted gut bacteria—and covers how to diagnose and treat infections caused by organisms like Candida, Aspergillus, and Cryptococcus. The review serves as a practical clinical guide given the high mortality these infections carry in this population.

PubMed

Liquid biopsy kinetics and detection of ERBB2 amplification/HER2-positivity in refractory hepatocellular carcinoma.

2023

The journal of liquid biopsy

Geddam AS, Lutfi A, Afghan MK, Currie BM, Rosenblatt R +4 more

Plain English
This case report describes a patient with advanced liver cancer whose routine liquid biopsy unexpectedly found an extreme amplification of the HER2 gene, a target normally associated with breast and gastric cancers. The team confirmed the finding with tissue testing and successfully used a dual HER2-blocking drug combination, tracking the response through blood tests and circulating tumor cells. The case illustrates that liquid biopsy can uncover actionable targets in liver cancer patients who might otherwise have no targeted treatment options.

PubMed

Black patients and women have reduced access to liver transplantation for alcohol-associated liver disease.

2023

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Kaplan A, Wahid N, Fortune BE, Verna E, Halazun K +3 more

Plain English
Using national mortality and transplant listing data from 2014 to 2018, researchers found that patients with alcohol-related liver disease have far lower rates of liver transplant listing relative to deaths than patients with other liver diseases—and within that group, Black patients and women face the greatest disadvantage. Black patients with alcohol-related liver disease were listed at half the rate of White patients. These findings call for targeted interventions to address compounded disparities in transplant access.

PubMed

National survey of second opinions for hospitalized patients in need of liver transplantation.

2023

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Kaplan A, Lee-Riddle GS, Nobel Y, Dove L, Shenoy A +4 more

Plain English
A national survey of 60 U.S. liver transplant programs examined how often and under what circumstances centers refer declined patients for a second opinion at another center. While all centers receive second-opinion referrals, only 25% frequently facilitate them for their own declined patients, and practices vary widely with no standardized process. Standardizing second-opinion pathways could improve equity for patients denied transplant listing.

PubMed

Association of chronic liver disease with cognition and brain volumes in two randomized controlled trial populations.

2022

Journal of the neurological sciences

Basu E, Mehta M, Zhang C, Zhao C, Rosenblatt R +2 more

Plain English
Researchers used data from two large randomized trials—one in diabetic patients, one in hypertensive patients—to test whether chronic liver disease is linked to worse cognitive function or smaller brain volumes. After adjusting for relevant factors, no consistent association was found between liver disease markers and cognitive test scores or brain imaging results in either group. This suggests that in people with diabetes or hypertension, liver disease does not independently drive cognitive decline, though the question remains open in other populations.

PubMed

Symptom Management in Patients with Cirrhosis: a Practical Guide.

2022

Current treatment options in gastroenterology

Kaplan A, Rosenblatt R

Plain English
This practical review guides clinicians through managing the range of symptoms that affect patients with cirrhosis, from ascites and brain dysfunction to pain, fatigue, and depression. It addresses the added complexity of prescribing medications in cirrhosis patients, whose altered liver function changes how drugs are processed and can cause harm at standard doses. The review is designed to give hepatologists concrete, evidence-based tools for improving quality of life in this challenging patient population.

PubMed

Introducing the Certificate of Added Qualification (CAQ) Corner.

2022

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Sharma P, Cardenas A, Aby ES, Rosenblatt R, Brown RS

PubMed

An Unusual Cause of Right Upper Quadrant Pain With Abnormal Liver Enzymes.

2022

Gastroenterology

Magahis P, Rosenblatt R, Mahadev S

PubMed

Association between liver fibrosis and incident dementia in the UK Biobank study.

2022

European journal of neurology

Parikh NS, Kamel H, Zhang C, Kumar S, Rosenblatt R +6 more

Plain English
Using data from over 455,000 UK adults, researchers found that people with signs of advanced liver scarring were 52% more likely to develop dementia over time compared to those without liver disease, even after adjusting for many other risk factors. The association held across different types of dementia and was not explained by shared risk factors like diabetes or alcohol use. Liver fibrosis may be a meaningful and underappreciated contributor to brain health that warrants attention in dementia prevention.

PubMed

Trends in Industry Payments to Gastroenterologists and Hepatologists in the United States From 2014 to 2020.

2022

Gastroenterology

Ying X, Rosenblatt R, Fortune BE

PubMed

Testing for ammonia: do as I say, not as we do.

2022

Frontline gastroenterology

Louissaint J, Rosenblatt R

PubMed

Ending Disparities in Liver Transplantation: The Time to Act Is Now.

2022

The American journal of gastroenterology

Kaplan A, Wahid N, Rosenblatt R

PubMed

Infections in Alcoholic Hepatitis.

2022

Journal of clinical and translational hepatology

Kaur B, Rosenblatt R, Sundaram V

Plain English
This review covers the types of infections that occur in patients with severe alcoholic hepatitis, who face a double vulnerability: their liver disease weakens the immune system, and the standard treatment—corticosteroids—can further impair infection-fighting ability. It examines the evidence on whether corticosteroids actually increase infection risk (more nuanced than once thought) and provides guidance on diagnosis, antibiotic selection, and preventive strategies. Prompt infection recognition and treatment are critical because infections dramatically worsen survival in this group.

PubMed

Practices and Perceptions of Living Donor Liver Transplantation, Nondirected Donation, and Liver Paired Exchange: A National Survey.

2022

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Kaplan A, Rosenblatt R, Jackson W, Samstein B, Brown RS

Plain English
A national survey of 99 liver transplant programs explored current use of nondirected living liver donation (where a stranger donates to an unknown recipient) and liver paired exchange (where incompatible donor-recipient pairs swap). Most programs accepting living donors allowed nondirected donation, but only 12% performed paired exchange, though 78% said they would participate if logistical barriers were resolved. Understanding these gaps can guide policy efforts to make more flexible forms of living donation routine.

PubMed

Sociodemographic characteristics of living liver donors: Few changes over 20 years.

2022

Clinical transplantation

Kaplan A, Wahid N, Lee J, Fortune BE, Halazun KJ +4 more

Plain English
Researchers analyzed 20 years of national data on living liver donors and found that the demographic profile has changed very little: donors remain predominantly young, White, employed, and college-educated, with a recent rise in female donors. The narrow socioeconomic and racial profile of donors likely reflects structural barriers to donation rather than medical exclusions. Addressing financial and social obstacles to donation is essential to diversify the donor pool.

PubMed

Frequent Co-Authors

Xiaohan Ying Brett E Fortune Arun Jesudian Alyson Kaplan Robert S Brown Nicole Ng Catherine Lucero Benjamin Samstein Nabeel Wahid Randall Rosenblatt

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.